Supports translational research and clinical feasibility studies to advance therapeutic and diagnostic devices for nervous or neuromuscular disorders. Activities include prototype implementation, safety and efficacy testing, regulatory approvals, and clinical studies. The program involves milestone-driven cooperative agreements with NIH collaboration and funding for in-house and contracted research activities.
Eligible applicants include a wide range of U.S. organizations such as nonprofits, small businesses, institutions of higher education, tribal organizations, and government entities. Specific eligibility details are provided in the announcement.
